Charleston, SC, United States of America

Jane Jourdan



 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Jane Jourdan: Innovator in Medical Research

Introduction

Jane Jourdan is a prominent inventor based in Charleston, SC, known for her significant contributions to medical research. With a total of nine patents to her name, she has made remarkable strides in the field of health and medicine. Her work focuses on developing innovative solutions for treating and preventing various medical conditions.

Latest Patents

Among her latest patents are the Alpha connexin C-terminal (ACT) peptides and methods of use thereof. This patent provides compositions and methods for treating or preventing macular degeneration in subjects. Additionally, it includes methods for preserving organs and tissues for transplantation, as well as preventing cellular injury in organs or in subjects. Another notable patent involves the use of Alpha connexin C-terminal (ACT) peptides to promote wound healing and tissue regeneration following tissue injury in subjects.

Career Highlights

Jane has worked with the Medical University of South Carolina Foundation for Research Development, where she has contributed to various research initiatives. Her innovative approaches have garnered attention and respect within the medical community.

Collaborations

Throughout her career, Jane has collaborated with esteemed colleagues, including Robert G. Gourdie and Gautam Ghatnekar. These partnerships have further enhanced her research and development efforts.

Conclusion

Jane Jourdan's work exemplifies the impact of innovation in medical research. Her patents and collaborations highlight her commitment to advancing healthcare solutions. She continues to be a driving force in her field, contributing to significant advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…